Detalhe da pesquisa
1.
Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.
Am J Transplant
; 19(8): 2350-2357, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30891931
2.
The role of human CD46 in early xenoislet engraftment in a dual transplant model.
Xenotransplantation
; 26(6): e12540, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219218
3.
Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.
FASEB J
; 28(3): 1248-67, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24308972
4.
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
Blood
; 116(23): e118-27, 2010 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733160
5.
ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Carcinogenesis
; 31(3): 435-41, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20042635
6.
The type III TGF-beta receptor suppresses breast cancer progression.
J Clin Invest
; 117(1): 206-17, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17160136
7.
The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
Carcinogenesis
; 30(8): 1281-7, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19325136
8.
Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.
Carcinogenesis
; 30(2): 238-48, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19056927
9.
The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Cancer Res
; 67(3): 1090-8, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17283142
10.
Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Cancer Res
; 67(11): 5231-8, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17522389
11.
TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
Carcinogenesis
; 29(3): 528-35, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18174241
12.
Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
Carcinogenesis
; 29(5): 905-12, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18299279
13.
The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.
Carcinogenesis
; 28(12): 2491-500, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17768179
14.
Role of TGF-ß receptor III localization in polarity and breast cancer progression.
Mol Biol Cell
; 25(15): 2291-304, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24870032
15.
TGF-ß regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion.
Mol Biol Cell
; 25(22): 3528-40, 2014 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143398
16.
Ectodomain shedding of TßRIII is required for TßRIII-mediated suppression of TGF-ß signaling and breast cancer migration and invasion.
Mol Biol Cell
; 25(16): 2320-32, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24966170
17.
Endocardial cell epithelial-mesenchymal transformation requires Type III TGFß receptor interaction with GIPC.
Cell Signal
; 24(1): 247-56, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945156
18.
Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
J Biol Chem
; 283(47): 32527-33, 2008 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18775991
19.
Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling.
Science
; 301(5638): 1394-7, 2003 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12958365